Nonalcoholic Fatty Liver Disease Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Protected: Cannabis Extract Effects on Metabolic Parameters and Gut Microbiota Composition in a Mice Model of NAFLD and Obesity

Freedom WaresJune 26, 2022

Canna~Fangled Abstracts

Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet

Cannabis Cannabinoid Res. 2020 Sep 2;5(3):202-214. doi: 10.1089/can.2020.0013.eCollection 2020. Tal Assa-Glazer 1, Jonathan Gorelick 2, Noa Sela 3, Abraham Nyska 4, Nirit Bernstein 5, Zecharia…

Freedom WaresSeptember 2, 2020

Canna~Fangled Abstracts

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.

Medicines (Basel). 2018 May 28;5(2). pii: E47. doi: 10.3390/medicines5020047. Dibba P1, Li A2, Cholankeril G3,…

Freedom WaresMay 28, 2018

Canna~Fangled Abstracts

Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.

PLoS One. 2017 Oct 19;12(10):e0186702. doi: 10.1371/journal.pone.0186702. eCollection 2017. Kim D1, Kim W2, Kwak MS3,…

Freedom WaresOctober 19, 2017

Canna~Fangled Abstracts

Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model.

Proteomics. 2016 Dec 8. doi: 10.1002/pmic.201600292. Chen CC1,2, Lee TY2, Kwok CF3, Hsu YP4, Shih KC5, Lin YJ6, Ho LT1,3,4,7. Author information…

Freedom WaresDecember 8, 2016

Canna~Fangled Abstracts

Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease.

2015;2015:842108. doi: 10.1155/2015/842108. Epub 2015 May 11. Jorgačević B1, Mladenović D1, Ninković M2, Vesković M1, Dragutinović V3, Vatazević A4, Vučević D1, Ješić…

Freedom WaresMay 11, 2015

Nonalcoholic Fatty Liver Disease

Protected: Cannabis Extract Effects on Metabolic Parameters and Gut Microbiota Composition in a Mice Model of NAFLD and Obesity

Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.

Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.

Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model.

Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease.

Recent Posts

Archives

Categories